Seattle, WA – According to filings with the U.S. Securities and Exchange Commission, Blaze Bioscience is raising $25,237,759.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Heather Franklin played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Blaze Bioscience

Blaze Bioscience, Inc. is a privately held biotechnology company dedicated to improving the lives of cancer patients. Blaze was founded in 2010 by Dr. Jim Olson, a pediatric neuro-oncologist at the Fred Hutchinson Cancer Research Center and Seattle Children’s Hospital, and Heather Franklin, a former senior business executive from ZymoGenetics. Blaze is working to develop Tumor Paint products and related therapeutics.

To learn more about Blaze Bioscience, visit http://www.blazebioscience.com/

Contact:
Heather Franklin, President and Chief Executive Officer
206-535-8144
heather.franklin@blazebioscience.com
https://www.linkedin.com/in/heatherlfranklin/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved